Skip to content

Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion

Comparison of Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion in Nulliparous Women : a Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04505943
Enrollment
200
Registered
2020-08-10
Start date
2020-09-01
Completion date
2021-09-30
Last updated
2020-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IUCD Complication

Brief summary

To compare the effect of vaginal dinoprostone versus vaginal misoprostol and Isonicotinic Acid Hydrazide administered before the copper intrauterine device(IUD) insertion in reducing IUD inertion pain and the difficulty in inserting the IUD in nulliparous women.

Detailed description

Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable, effective and long term contraception for many women. However, the insertion procedure can be associated with a troublesome degree of pain that prevent some women from choosing its use. Different interventions have been described to decrease pain perception during intrauterine device insertion with no agreement on an effective one.

Interventions

2 vaginal tablet of isonicotinic acid hydrazide inserted by the study nurse12 hours before IUD insertion.

DRUGdinoprostine

2 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia & Upjohn, Puurs, Belgium) inserted by the study nurse 3 hours before IUD insertion.

DRUGmisoprostol

2 vaginal tablet of misoprostol (200 mcg) (Misotac®; Sigma Pharma, SAE, Egypt) inserted by the study nurse 3 hours before IUD insertion

Sponsors

Aswan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

randomized controlled trial

Intervention model description

randomized controlled trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* nulliparous women requesting copper IUD insertion

Exclusion criteria

* pregnancy, * Parous women, * contraindications or allergy to dinoprostone or misoprostol,contraindication to IUD insertion, * untreated active cervicitis or vaginitis, * undiagnosed abnormal uterine bleeding

Design outcomes

Primary

MeasureTime frameDescription
The difference in visual analog scale pain scores during intrauterine device insertion10 minutsThe difference in pain scores during intrauterine device insertion using visual analog scale from 0 to 10

Secondary

MeasureTime frameDescription
the difference in visual analog scale pain scores during tenaculum application10 minutsThe difference in pain scores during tenaculum application using a visual analog scale from 0 to 10
the ease of IUD insertion10 minutesthe ease of IUD insertion using ease of insertion score from 0 to 10 cm (0 = very easy insertion, 10 cm = terribly difficult insertion)
women's satisfaction level: score10 minuteswomen's satisfaction level using satisfaction score from 0 to 10 cm where 0 denotes no satisfaction and 10 denotes maximum satisfaction

Countries

Egypt

Contacts

Primary Contacthany f Sallam, md
hany.farouk@aswu.edu.eg+20102435461
Backup Contactnahla w Shady, md
hanygyne@yahoo.com+201022336052

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026